AUTOMATIC IMPLANTABLE CARDIOVERTER DEFIBRILLATOR - SURGICAL APPROACHES FOR IMPLANTATION

被引:8
作者
SHEPARD, RB
GOLDIN, MD
LAWRIE, GM
WATKINS, L
WINKLE, RA
MOWER, MM
THOMAS, AC
NISAM, S
机构
[1] Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama
[2] Department of Cardiovascular and Thoracic Surgery, Rush Medical College, Chicago, Illinois
[3] Department of Surgery, Baylor College of Medicine, Houston, Texas
[4] Department of Surgery, Johns Hopkins Medical Institutes, Baltimore, Maryland
[5] Cardiac Surveillance Unit, Electrophysiology Laboratory Sequoia Hospital, Redwood, California
[6] Cardiac Pacemakers, Inc, St.Paul, Minnesota
关键词
DEFIBRILLATION; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA; SURGICAL TECHNIQUE; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR;
D O I
10.1111/j.1540-8191.1992.tb00804.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Surgical approaches for implantation of the automatic cardioverter defibrillator are sternotomy, left thoracotomy, subxiphoid, and subcostal. Although any one of these may be combined with insertion of one or more of the electrodes transvenously, surgical entry into the chest is required for every noninvestigational defibrillator implantation operation. The approaches differ in exposure provided for selecting electrode sites and for handling untoward events, in amount and location of tissue that must be divided or dissected, and in average time required. The operation is an electrical one. Its purpose is to obtain reliable rhythm sensing so that defibrillation or cardioversion shocks will occur only when necessary, and to obtain low enough defibrillation thresholds for shocks of 30 joules or less to have a 10-joule defibrillation safety margin. Many of the patients have had previous cardiac operations. They usually have low or very low ejection fractions. Intraoperative electrophysiological testing with often multiple defibrillation episodes is required. The choice of approach varies with the state of the patient, the institutional experience, and the surgeon. This article describes techniques, and the advantages and disadvantages of the four approaches as used by four surgeons in four different institutions.
引用
收藏
页码:208 / 224
页数:17
相关论文
共 16 条
[1]  
Mirowski M, Reid P, Mower M, Et al., Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings, N Engl J Med, 303, (1980)
[2]  
CPI Clinical Database and Device Registry, (1990)
[3]  
Kelly P, Cannom D, Garan H, Et al., The automatic implantable cardioverter defibrillator: Efficacy complications and survival in patients with malignant ventricular arrhythmias, J Am Coll Cardiol, 11, (1988)
[4]  
Tchou P, Kadri N, Anderson J, Et al., Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias, Annals of Internal Medicine, 109, (1988)
[5]  
Winkle R, Mead H, Ruder M, Et al., Long‐term outcome with the automatic implantable cardioverter‐defibrillator, J Am Coll Cardiol, 13, (1989)
[6]  
Lehmann M, Steinman R, Shuger C, Et al., The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to myocardial infarction, Am J Cardiol, 62, (1988)
[7]  
Mirowski M, Mower M, Reid P, Et al., The automatic implantable defibrillator: New modality for treatment of life‐threatening ventricular arrhythmias, PACE, 5, (1982)
[8]  
Mower M, Reid P, Watkins L, Et al., Automatic implantable cardioverter defibrillator structural characteristics, PACE, 7, (1984)
[9]  
Nisam S, The automatic implantable cardioverter defibrillator (AICD)—A clinical and technical review, J Med Eng Tech, 11, (1987)
[10]  
Mirowski M, The automatic implantable cardioverter defibrillator: An overview, J Am Coll Cardiol, 6, (1985)